The Impact of Aspirin Resistance on the Long‐term Cardiovascular Mortality in Patients with Non‐ST Segment Elevation Acute Coronary Syndromes
Open Access
- 19 March 2009
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 32 (3) , 142-147
Abstract
Background Aspirin resistance has been associated with an adverse long-term outcome in patients with atherosclerotic coronary artery disease, but more studies are needed. Hypothesis The aim of this study was to investigate the impact of aspirin resistance, assessed by the Platelet Function Analyzer-100 (PFA-100) (Dade Behring Inc., Deerfield, Ill., USA) on the long-term prognosis in patients with non-ST segment elevation acute coronary syndromes (NSTE-ACS). Methods A total of 496 consecutive patients were studied. The 1-y incidence of cardiovascular death was the prespecified study endpoint. The patients were divided, according to the values of PFA-100 collagen epinephrine closure time (CEPI-CT) upon presentation, into aspirin sensitives (those with a PFA-100 CEPI-CT > 193 sec) and aspirin resistants (those with a PFA-100 CEPI-CT ≤ 193 sec). Results Aspirin resistants were younger (p-value = 0.04), and less frequently hypertensives (p-value = 0.05) or diabetics (p-value = 0.04) than aspirin sensitives. By 1 y, the incidence of cardiovascular deaths in the entire cohort was 12.9% (64/496), and aspirin resistants were at significantly higher risk of cardiovascular death (23.1% versus 9.6%; hazard ratio [HR] = 2.6; 95% confidence interval [CI] = 1.6–4.3; p-value < 0.001), than aspirin sensitives. By multivariate Cox regression analysis, aspirin resistance (a PFA-100 CEPI-CT ≤ 193 sec) was among the most potent predictors of the 1-y incidence of cardiovascular death (HR = 2.8; 95% CI = 1.7–4.6; p-value < 0.001). Conclusion According to the present data, aspirin resistance, assessed by the PFA-100, is an independent predictor of long-term cardiovascular mortality in patients with NSTE-ACS. CopyrightKeywords
This publication has 10 references indexed in Scilit:
- Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACSJournal of Thrombosis and Haemostasis, 2006
- Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: A 6 months prospective studyThrombosis Research, 2006
- Aspirin and Clopidogrel Drug Response in Patients Undergoing Percutaneous Coronary InterventionJACC, 2006
- Variables influencing Platelet Function Analyzer‐100TM closure times in healthy individualsBritish Journal of Haematology, 2005
- Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levelsThrombosis Journal, 2005
- Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatmentJACC, 2004
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJACC, 2003
- Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular EventsCirculation, 2002
- Profile and prevalence of aspirin resistance in patients with cardiovascular diseaseThe American Journal of Cardiology, 2001
- Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patientsThrombosis Research, 1993